Bexarotene是一种高亲和力、选择性类视黄醇X受体激动剂，临床上用于皮肤T细胞淋巴瘤的治疗研究。
| 英文别名 (English Synonym) | Bexarotene |
| 中文名称 (Chinese Name) | 贝沙罗汀 |
| 靶点 (Target) | Retinoid X Receptors |
| 通路 (Pathway) | Others |
| CAS号 (CAS NO.) | 153559-49-0 |
| 分子式 (Formula) | C24H28O2 |
| 分子量 (Molecular Weight) | 348 |
| 纯度 (Purity) | ≥98% |
| 溶解性 (Solubility) | 溶于DMSO |
-25~-15℃保存，有效期3年
[1] de Almeida NR, Conda-Sheridan M. A review of the molecular design and biological activities of RXR agonists. Med Res Rev. 2019 Jul;39(4):1372-1397. doi: 10.1002/med.21578. Epub 2019 Apr 3. PMID: 30941786; PMCID: PMC6565479.[2]Shen D, Wang H, Zheng Q, Cheng S, Xu L, Wang M, Li GH, Xia LQ. Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer. Onco Targets Ther. 2019 Sep 24;12:7877-7886. doi: 10.2147/OTT.S209307. Erratum in: Onco Targets Ther. 2019 Oct 25;12:8807. doi: 10.2147/OTT.S235000. PMID: 31576145; PMCID: PMC6768013.[3]Wang Y, Zhang Z, Yao R, Jia D, Wang D, Lubet RA, You M. Prevention of lung cancer progression by bexarotene in mouse models. Oncogene. 2006 Mar 2;25(9):1320-9. doi: 10.1038/sj.onc.1209180. PMID: 16247446.
